Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,661,491

« Back to Dashboard

Summary for Patent: 4,661,491

Title: Alfuzosine compositions and use
Abstract:A method for treating humans or non-human animals for dysuria comprising administering an effective non-toxic amount of alfuzosine or a pharmaceutically acceptable salt thereof to a human or non-human animal suffering dysuria.
Inventor(s): Regnier; Francois (Nancy, FR)
Assignee: Synthelabo (Paris, FR)
Application Number:06/867,031
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 4,661,491

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 07950May 28, 1985

International Patent Family for Patent: 4,661,491

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia5795186► Subscribe
Australia586684► Subscribe
Canada1261755► Subscribe
Germany3683318► Subscribe
Denmark168029► Subscribe
Denmark246586► Subscribe
European Patent Office0204597► Subscribe
France2582513► Subscribe
HungaryT46221► Subscribe
Ireland58595► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: